CHEST Physician
-
First-line zongertinib demonstrates durable responses in HER2-mutant NSCLC
Brett Bade, MD, and Katie Smith, MD, said the expansion of targeted therapies for lung cancer is an important advance, while noting that questions remain regarding the drug’s role in the first-line setting.
-
Exercise-induced desaturation common among patients with COPD during early inpatient PR
Michele Vitacca, MD, and Mara Paneroni, PhD, said data show a disconnect between oxygen desaturation and symptom measures, highlighting the importance of objective physiological monitoring.
-
TETON-1 treatment effects offer hope for patients with idiopathic pulmonary fibrosis
Christopher King, MD, FCCP, and Steven D. Nathan, MD, FCCP, discuss the clinical implications of inhaled treprostinil, including the medication’s potential use in future combination treatment strategies.
-
Study compares antibiotic prescribing in primary care telemedicine vs in-person visits for pediatric ARTIs
Kristin N. Ray, MD, MS, and Samuel R. Wittman, MS, discussed how telemedicine delivered through primary care practices was associated with lower antibiotic use while maintaining guideline-concordant care.
-
The measurable medical and financial benefits of transitional care
The combination of readmission reduction efforts and transitional care billing made it possible for a group of APPs to launch an effective transitional care clinic for patients with COPD.
-
Impossible choices: Goal-concordant care in the ICU
Clinicians should approach discussions about goal-concordant care with curiosity, humility, and responsibility, for the benefit of both the patient and their family.
-
Recognizing OSA in women: The peri-operative opportunity
OSA in women continues to be underrecognized because it often presents differently than the classic OSA phenotype that has shaped clinical recognition for decades.
-
How social determinants of health impact lung cancer care
Patient outcomes in lung cancer care vary greatly by race, geography, income, and access to care. Learn how experts are addressing disparities through education, screening, and culturally responsive and personalized care.
-
Setidegrasib demonstrates durable responses in KRAS G12D-mutant NSCLC
Coauthor Anup Kasi, MD, MPH, said the study represents an important step forward in the development of KRAS G12D-targeted therapies.
-
Study links isoflavone intake to reduced COPD morbidity
Mariah K. Jackson, PhD, RDN, LMNT, said that while the research does not establish causality, nutrition is generally a safe, well-tolerated, and cost-effective strategy to improve respiratory health.
